Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation

Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer. Endocrine therapies targeting the ER represent one of the most successful anticancer strategies to date. In the clinic, novel targeted agents are now being exploited in combination with established endocrine therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Simon J., Cheung, Kwok-Leung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360014/
https://www.ncbi.nlm.nih.gov/pubmed/32700026
http://dx.doi.org/10.1007/s40487-018-0062-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360014/
https://www.ncbi.nlm.nih.gov/pubmed/32700026
http://dx.doi.org/10.1007/s40487-018-0062-x

Ejemplares similares